Global Alvimopan Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Alvimopan Market
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Due to the COVID-19 pandemic, the global Alvimopan market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Alvimopan global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Pharmaceutical Grade

Others

Segment by Application

Pharmaceutical

Other

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Alvimopan market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Merck

Teva Pharmaceutical Industries Ltd

MSN Life Sciences Private Ltd

1 Study Coverage
1.1 Alvimopan Product Introduction

1.2 Market by Type

1.2.1 Global Alvimopan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Pharmaceutical Grade

1.2.3 Others

1.3 Market by Application

1.3.1 Global Alvimopan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Pharmaceutical

1.3.3 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Alvimopan Sales Estimates and Forecasts 2017-2028

2.2 Global Alvimopan Revenue Estimates and Forecasts 2017-2028

2.3 Global Alvimopan Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Alvimopan Sales by Region

2.4.1 Global Alvimopan Sales by Region (2017-2022)

2.4.2 Global Sales Alvimopan by Region (2023-2028)

2.5 Global Alvimopan Revenue by Region

2.5.1 Global Alvimopan Revenue by Region (2017-2022)

2.5.2 Global Alvimopan Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Alvimopan Sales by Manufacturers

3.1.1 Global Top Alvimopan Manufacturers by Sales (2017-2022)

3.1.2 Global Alvimopan Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alvimopan in 2021

3.2 Global Alvimopan Revenue by Manufacturers

3.2.1 Global Alvimopan Revenue by Manufacturers (2017-2022)

3.2.2 Global Alvimopan Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Alvimopan Revenue in 2021

3.3 Global Alvimopan Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Alvimopan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Alvimopan Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Alvimopan Sales by Type

4.1.1 Global Alvimopan Historical Sales by Type (2017-2022)

4.1.2 Global Alvimopan Forecasted Sales by Type (2023-2028)

4.1.3 Global Alvimopan Sales Market Share by Type (2017-2028)

4.2 Global Alvimopan Revenue by Type

4.2.1 Global Alvimopan Historical Revenue by Type (2017-2022)

4.2.2 Global Alvimopan Forecasted Revenue by Type (2023-2028)

4.2.3 Global Alvimopan Revenue Market Share by Type (2017-2028)

4.3 Global Alvimopan Price by Type

4.3.1 Global Alvimopan Price by Type (2017-2022)

4.3.2 Global Alvimopan Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Alvimopan Sales by Application

5.1.1 Global Alvimopan Historical Sales by Application (2017-2022)

5.1.2 Global Alvimopan Forecasted Sales by Application (2023-2028)

5.1.3 Global Alvimopan Sales Market Share by Application (2017-2028)

5.2 Global Alvimopan Revenue by Application

5.2.1 Global Alvimopan Historical Revenue by Application (2017-2022)

5.2.2 Global Alvimopan Forecasted Revenue by Application (2023-2028)

5.2.3 Global Alvimopan Revenue Market Share by Application (2017-2028)

5.3 Global Alvimopan Price by Application

5.3.1 Global Alvimopan Price by Application (2017-2022)

5.3.2 Global Alvimopan Price Forecast by Application (2023-2028)

6 North America

6.1 North America Alvimopan Market Size by Type

6.1.1 North America Alvimopan Sales by Type (2017-2028)

6.1.2 North America Alvimopan Revenue by Type (2017-2028)

6.2 North America Alvimopan Market Size by Application

6.2.1 North America Alvimopan Sales by Application (2017-2028)

6.2.2 North America Alvimopan Revenue by Application (2017-2028)

6.3 North America Alvimopan Market Size by Country

6.3.1 North America Alvimopan Sales by Country (2017-2028)

6.3.2 North America Alvimopan Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Alvimopan Market Size by Type

7.1.1 Europe Alvimopan Sales by Type (2017-2028)

7.1.2 Europe Alvimopan Revenue by Type (2017-2028)

7.2 Europe Alvimopan Market Size by Application

7.2.1 Europe Alvimopan Sales by Application (2017-2028)

7.2.2 Europe Alvimopan Revenue by Application (2017-2028)

7.3 Europe Alvimopan Market Size by Country

7.3.1 Europe Alvimopan Sales by Country (2017-2028)

7.3.2 Europe Alvimopan Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Alvimopan Market Size by Type

8.1.1 Asia Pacific Alvimopan Sales by Type (2017-2028)

8.1.2 Asia Pacific Alvimopan Revenue by Type (2017-2028)

8.2 Asia Pacific Alvimopan Market Size by Application

8.2.1 Asia Pacific Alvimopan Sales by Application (2017-2028)

8.2.2 Asia Pacific Alvimopan Revenue by Application (2017-2028)

8.3 Asia Pacific Alvimopan Market Size by Region

8.3.1 Asia Pacific Alvimopan Sales by Region (2017-2028)

8.3.2 Asia Pacific Alvimopan Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Alvimopan Market Size by Type

9.1.1 Latin America Alvimopan Sales by Type (2017-2028)

9.1.2 Latin America Alvimopan Revenue by Type (2017-2028)

9.2 Latin America Alvimopan Market Size by Application

9.2.1 Latin America Alvimopan Sales by Application (2017-2028)

9.2.2 Latin America Alvimopan Revenue by Application (2017-2028)

9.3 Latin America Alvimopan Market Size by Country

9.3.1 Latin America Alvimopan Sales by Country (2017-2028)

9.3.2 Latin America Alvimopan Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Alvimopan Market Size by Type

10.1.1 Middle East and Africa Alvimopan Sales by Type (2017-2028)

10.1.2 Middle East and Africa Alvimopan Revenue by Type (2017-2028)

10.2 Middle East and Africa Alvimopan Market Size by Application

10.2.1 Middle East and Africa Alvimopan Sales by Application (2017-2028)

10.2.2 Middle East and Africa Alvimopan Revenue by Application (2017-2028)

10.3 Middle East and Africa Alvimopan Market Size by Country

10.3.1 Middle East and Africa Alvimopan Sales by Country (2017-2028)

10.3.2 Middle East and Africa Alvimopan Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Merck

11.1.1 Merck Corporation Information

11.1.2 Merck Overview

11.1.3 Merck Alvimopan Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Merck Alvimopan Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Teva Pharmaceutical Industries Ltd

11.2.1 Teva Pharmaceutical Industries Ltd Corporation Information

11.2.2 Teva Pharmaceutical Industries Ltd Overview

11.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Teva Pharmaceutical Industries Ltd Recent Developments

11.3 MSN Life Sciences Private Ltd

11.3.1 MSN Life Sciences Private Ltd Corporation Information

11.3.2 MSN Life Sciences Private Ltd Overview

11.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 MSN Life Sciences Private Ltd Alvimopan Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 MSN Life Sciences Private Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Alvimopan Industry Chain Analysis

12.2 Alvimopan Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Alvimopan Production Mode & Process

12.4 Alvimopan Sales and Marketing

12.4.1 Alvimopan Sales Channels

12.4.2 Alvimopan Distributors

12.5 Alvimopan Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Alvimopan Industry Trends

13.2 Alvimopan Market Drivers

13.3 Alvimopan Market Challenges

13.4 Alvimopan Market Restraints

14 Key Findings in The Global Alvimopan Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer